Why Depression Treatment Looks Different for Everyone
Depression is increasingly understood as a heterogeneous condition, meaning that two people can meet criteria for major depressive disorder while having very different underlying contributors, symptom patterns, and treatment needs. Research over the past several years has moved away from viewing depression as one single disease process and toward a more personalized model that considers biological, psychological, social, and environmental factors.
One growing area of research is the relationship between depression and inflammation. A 2025 review on immune-driven depression described a subgroup of major depressive disorder characterized by low-grade inflammation, changes in energy regulation, altered stress response, and higher rates of treatment resistance. This does not suggest that all depression is caused by inflammation, but it does support the idea that some individuals may have biological pathways that contribute to depressive symptoms.
Recent research has also explored whether immune-targeted treatments could help certain people with difficult-to-treat depression. A 2026 study from Mount Sinai reported that major depressive disorder may share immune abnormalities with inflammatory skin diseases, including pathways related to type 2 inflammation. Researchers identified possible therapeutic targets and discussed whether medications already used for inflammatory conditions may eventually be studied for depression subgroups.
Another early clinical trial examined tocilizumab, an anti-inflammatory medication commonly used for autoimmune conditions, in individuals with moderate to severe depression that had not responded well to standard antidepressant treatment. Although the study was small and requires replication, participants receiving the medication showed improvement in depression severity, fatigue, anxiety, and quality of life compared with placebo. These findings are preliminary, but they reflect a larger shift toward precision psychiatry.
Psychological research also supports this individualized view of depression. Depression is associated with cognitive patterns, avoidance, negative self-beliefs, trauma history, chronic stress, loneliness, relationship conflict, sleep disruption, and behavioral withdrawal. Evidence-based therapies such as cognitive behavioral therapy, behavioral activation, psychodynamic therapy, and mindfulness-based interventions may target different mechanisms depending on the person’s presentation and integration of health psychology. Our clinicians can help you determine what has been affecting you most by guiding you toward the next-best intervention pathway.
For therapy practices, this research reinforces an important clinical point: depression treatment should not be one-size-fits-all. A client presenting with depression related to grief, ADHD, burnout, trauma, relationship stress, or chronic avoidance may need a different treatment focus than a client whose symptoms are primarily marked by biological treatment resistance or severe fatigue. Clients who undergo treatment, if necessary, can work with the primary physician and therapist to help best conclude the root of their depression. Personalized depression treatment requires careful assessment, attention to context, and ongoing collaboration between therapy, primary care, and psychiatry when needed.
At Nurturing Life Counseling, therapy for depression in Hoboken and Jersey City, NJ, is informed by this broader research perspective. Depression is best understood by looking at the whole person, including symptoms, history, relationships, coping patterns, stressors, and strengths.
